Raw material API bulk purchases
Take advantage of favorable pricing windows and supply chain opportunities on API and excipient inventory.
FDA Validation Takes Months. Raw Material Buys Hit Today.
A working capital line of credit up to $1.5M for pharmaceutical manufacturers. Fund raw materials, compliance, and the validation cycles that bring products to market.
Capital for the long-cycle pharmaceutical economy.
Pharmaceutical and drug manufacturing is one of the most capital-intensive small business sectors. Raw material APIs require bulk purchases that tie up working capital for months. cGMP compliance demands ongoing investment in equipment, documentation, and quality systems. FDA validation cycles, from initial submission through approval, can run twelve to twenty-four months while costs accrue weekly. Add the operating costs of a compliant facility, the regulatory and legal fees of submissions, and the marketing and distribution infrastructure required at launch, and the working capital demands are continuous.
Commercial Capital Connect provides pharmaceutical manufacturers a working capital line of credit up to $1.5 million with interest-only options. Fund raw materials. Cover validation cycle operating costs. Support compliance and quality system investments. Same-day approvals and the flexibility to draw on the rhythm of your validation and production cycles.
cGMP compliance and quality system investment
Fund the ongoing compliance, documentation, and quality system investments that meet FDA standards.
Validation cycle operating capital
Cover operating costs during the long validation and approval cycles between submission and launch.
Lab expansion and equipment upgrades
Add analytical equipment, production capacity, and the lab infrastructure that supports growth.
Distribution and DSCSA compliance infrastructure
Fund the supply chain security, serialization, and distribution infrastructure required for modern pharma.
Basic line of credit review criteria
These are baseline review items, not an approval, offer, or commitment to lend.
- Estimated Equifax score of 575 or higher
- Operating at least 30 days
- About $17,000+ in average monthly revenue
- Active commercial business location
- 0 to 2 active cash advances preferred
Why Commercial Capital Connect
CCC is a business finance marketplace, not a direct lender. One application can help compare potential options through a network of 75+ lending partners.
Long-cycle businesses are familiar territory
We understand validation cycles and the working capital demands that accompany them.
Compliance-heavy operations are expected
We respect the regulatory complexity and underwrite to the operating reality.
Interest-only payment options
Keep monthly outlay lean during validation cycles and pay down principal as products launch.
Refinance restrictive financing
Pay off up to two existing cash advances or short-term loans into a flexible LOC.
Drug Manufacturers funding FAQ
Can a contract manufacturer (CMO) qualify?
Yes. CMOs qualify on the standard criteria: 575 Equifax, 30 days TIB, $200K annual revenue.
Can the line fund API inventory builds?
Yes. Raw material and API inventory builds are common and well-suited uses of working capital from the line.
What about FDA submission and regulatory fees?
Submission fees, regulatory consultants, and validation cycle operating costs are all valid working capital uses.
How does the line interact with NDA and ANDA pipelines?
The line provides general working capital that can support pipeline operations alongside other capital sources for product-specific development.
Can the line fund a facility expansion?
Working capital for facility expansion is a valid use. Larger expansion-specific structures may require additional documentation.